ClinicalTrials.gg
Sign In

BiologicalDrug

Autologous Anti-BCMA CAR T-cells IM21 clinical trials

studies test it
3
open now
0
in phase 3
0
first study started
2019

How studies write it

Studies that test it under each name

Name

IM21 CAR-T cells
3

Development codes

IM21
1

Studies by the year they started

3 studies that test it; most in 2019 (1)

Studies that test Autologous Anti-BCMA CAR T-cells IM21, by start year
YearStudies
20191
20201
20211

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
2

What it is tested for

Each study’s main condition, where its own words name it.

Multiple Myeloma
3

Who runs them

Industry 2 · Other 1

Beijing Immunochina Medical Science & Technology Co., Ltd. (2) · Peking Union Medical College Hospital (1)

Studies

Open first, then newest update. How each study uses Autologous Anti-BCMA CAR T-cells IM21 is read from its arms, and is right about nine times in ten.

Testing it · 3